Eli Lilly releases new, cheaper form of weight loss drug
Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly…
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March…
Eli Lilly raises outlook on bumper sales of diabetes and weight loss drugs
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Eli Lilly…
Novo Nordisk, Eli Lilly shares slide on Roche’s obesity drug trial
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel.SEBASTIEN BOZON | AFP | Getty ImagesNovo Nordisk and…
Lilly Bell Stars in Erika Lust Studio’s New Feature ‘Last Splash’
(Hollywood, CA) Multi-award-winning, all-natural, petite brunette beauty Lilly Bell has had some breakout roles in features this year, and her leading…
UK Planning Laws Hinder Investment, Warns Eli Lilly CEO
The head of the world’s most valuable pharmaceutical company has criticised the UK’s planning system, claiming it deters investment. Dave…
Lilly Pulitzer Surprise 60% Off Deals Just Launched: Don’t Miss Out
We independently selected these deals and products because we love them, and we think you might like them at these…
Lilly, Zoetis, Abbott least shorted stocks in S&P 500 health sector in mid-Jan
Short interest in healthcare stocks ticked higher from the end of 2023, with bets against healthcare provider and services ranking…
Lilly, Novo Nordisk top pharma performers in August
marekuliasz/iStock via Getty Images Sales of diabetes and weight loss drugs are booming, propelling Eli Lilly (NYSE:LLY) and Novo Nordisk…
Nektar Therapeutics sues Eli Lilly over autoimmune disease treatment
(Reuters) - Nektar Therapeutics on Monday sued Eli Lilly, accusing the drugmaker of undermining the prospects for Rezpeg, which Nektar…
